Loading
Latest filing published 27 Jan 2020 for Eagle Pharmaceuticals, INC., €86k.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Pete A. Meyers in Eagle Pharmaceuticals, Inc. The record holds 8 filings, for trades running from 12 June 2017 to 23 January 2020.
Purchases make up the whole of the open-market record (2 purchases, €39k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 6 share grants.
The latest filing, published on 27 January 2020, reports a share grant of €86k in Eagle Pharmaceuticals, Inc. The last purchase on record was published on 16 August 2017, which is 3,355 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations